Filaggrin null mutations are associated with increased asthma severity in children and young adults

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 1, 2007, Pages 64-68

  Palmer, Colin N A ^a   Ismail, Tahmina ^b   Lee, Simon P ^a   Terron Kwiatkowski, Ana ^c   Zhao, Yiwei ^c   Liao, Haihui ^c   Smith, Frances J D ^c   McLean, W H Irwin ^c   Mukhopadhyay, Somnath ^b  

^a Biomedical Research Center   (United Kingdom)

^b PERTH ROYAL INFIRMARY   (United Kingdom)

^c Epithelial Genetics Group   (United Kingdom)

Author keywords

asthma; atopy; control; eczema; keratinization; lung function; Skin barrier; treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FILAGGRIN; FORMOTEROL; MONTELUKAST; SALBUTAMOL; SALMETEROL; STEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; ECZEMA; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MUTATION; VITAL CAPACITY;

EID: 34250797912     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.04.001     Document Type: Article

References (25)

1. Candi E., Schmidt R., and Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6 (2005) 328-340
2. Palmer C.N.A., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
3. Smith F.J.D., Irvine A.D., Terron-Kwiatkowski A., Sandilands A., Campbell L.E., Zhao Y., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38 (2006) 337-342
4. Weidinger S., Illig T., Baurecht H., Irvine A.D., Rodriguez E., Diaz-Lacava A., et al. Loss-of-function variants within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118 (2006) 214-219
5. Barker J.N., Palmer C.N.A., Zhao Y., Liao H., Hull P.R., Lee S.P., et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 127 (2007) 564-567
6. Ruether A., Stoll M., Schwarz T., Schreiber S., and Folster-Holst R. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 155 (2006) 1093-1094
7. Stemmler S., Parwez Q., Petrasch-Parwez E., Epplen J.T., and Hoffjan S. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 127 (2006) 722-724
8. Morar N., Cookson W.O., Harper J.I., and Moffatt M.F. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol (2007) Feb 15 [Epub ahead of print]
9. Marenholz I., Nickel R., Ruschendorf F., Schulz F., Esparza-Gordillo J., Kerscher T., et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118 (2006) 866-871
10. Irvine A.D. Fleshing out filaggrin phenotypes. J Invest Dermatol 127 (2007) 504-507
11. Nomura T., Sandilands A., Akiyama M., Liao H., Evans A.T., Sakai K., et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119 (2007) 434-440
12. Spergel J.M., and Paller A.S. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112 suppl 6 (2003) S118-S127
13. Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., and Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101 (1998) 1614-1622
14. Corbo G.M., Foresi A., Morandini S., Valente S., Mattoli S., and Ciappi G. Probit analysis applied to the allergen dose-response curve: A method for epidemiologic surveys. J Allergy Clin Immunol 81 (1988) 41-47
15. Kopferschmitt-Kubler M.C., Bigot H., and Pauli G. Allergen bronchial challenge tests: variability and reproducibility of the early response. J Allergy Clin Immunol 80 (1987) 730-740
16. Segre J.A. Epidermal barrier formation and recovery in skin disorders. J Clin Invest 116 (2006) 1150-1158
17. Palmer C.N.A., Doney A.S., Lee S.P., Murrie I., Ismail T., Macgregor D.F., et al. Glutathione-S-transferase M1 and P1 genotype, passive smoking and peak expiratory flow in asthma. Pediatrics 118 (2006) 710-716
18. BTS/SIGN. British guidelines on the management of asthma. Thorax 58 suppl 1 (2003) 1-94
19. Gilbert R., and Auchincloss J.H.J. The interpretation of the spirogram: how accurate is it for "obstruction"?. Arch Intern Med 145 (1985) 1635-1639
20. Timonen K.L., Pekkanen J., Korppi M., Vahteristo M., and Salonen R.O. Prevalence and characteristics of children with chronic respiratory symptoms in eastern Finland. Eur Respir J 8 (1995) 1155-1160
21. Kondo H., Ichikawa Y., and Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 28 (1998) 769-779
22. Strid J., and Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 4 (2005) 531-541
23. Yamaguchi M., Sayama K., Yano K., Lantz C.S., Noben-Trauth N., Ra C., et al. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 162 (1999) 5455-5465
24. Yamaguchi M., Lantz C.S., Oettgen H.C., Katona I.M., Fleming T., Miyajima I., et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 185 (1997) 663-672
25. Arshad S.H. Primary prevention of asthma and allergy. J Allergy Clin Immunol 116 (2005) 3-14